Alector (ALEC) Depreciation & Amortization (CF) (2018 - 2026)
Alector (ALEC) posted quarterly Depreciation & Amortization (CF) of $1.1 million for Q1 2026, up 9.86% year-over-year from $984000.0 in Q1 2025, and down 7.45% quarter-over-quarter from $1.2 million in Q4 2025.
Alector (ALEC) Depreciation & Amortization (CF) (2018 - 2026) Analysis & Trends
Alector (ALEC) has reported Depreciation & Amortization (CF) for 9 consecutive years, with $1.1 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Depreciation & Amortization (CF) rose 9.86% year-over-year to $1.1 million; the TTM figure through Mar 2026 stood at $5.8 million (up 17.52% YoY), while the FY2025 annual figure was $5.7 million, up 5.75% from the prior year.
- Depreciation & Amortization (CF) eased to $1.1 million in Q1 2026 per ALEC's latest filing, from $1.2 million in the prior quarter.
- Across five years, Depreciation & Amortization (CF) topped out at $2.3 million in Q2 2025 and bottomed at $984000.0 in Q1 2025.
- Historically, Depreciation & Amortization (CF) has averaged $1.4 million across 5 years, with a median of $1.4 million in 2022.
- On a YoY basis, Depreciation & Amortization (CF) climbed as much as 65.88% in 2025 and fell as far as 31.81% in 2025.
- Alector's Depreciation & Amortization (CF) stood at $1.4 million in 2022, then increased by 3.08% to $1.4 million in 2023, then decreased by 13.57% to $1.2 million in 2024, then declined by 5.96% to $1.2 million in 2025, then slipped by 7.45% to $1.1 million in 2026.
- Business Quant data shows ALEC's Depreciation & Amortization (CF) at $1.1 million in Q1 2026, $1.2 million in Q4 2025, and $1.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 56.50 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 123.70 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 2.10 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 40.52 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 3.18 Mn |
| 10 | Alector | 218.85 Mn | 46.05 Mn | - | 1.05 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.05 Mn |
| Jun 30, 2026 | 1.05 Mn |
| Mar 31, 2026 | 1.08 Mn |
| Mar 31, 2026 | 1.08 Mn |
| Dec 31, 2025 | 1.17 Mn |
| Dec 31, 2025 | 1.17 Mn |
| Sep 30, 2025 | 1.24 Mn |
| Sep 30, 2025 | 1.24 Mn |
| Jun 30, 2025 | 2.33 Mn |
| Jun 30, 2025 | 2.33 Mn |
| Mar 31, 2025 | 984,000.00 |
| Mar 31, 2025 | 984,000.00 |
| Dec 31, 2024 | 1.24 Mn |
| Dec 31, 2024 | 1.24 Mn |
| Sep 30, 2024 | 1.32 Mn |
| Sep 30, 2024 | 1.32 Mn |
| Jun 30, 2024 | 1.40 Mn |
| Jun 30, 2024 | 1.40 Mn |
| Mar 31, 2024 | 1.44 Mn |
| Mar 31, 2024 | 1.44 Mn |